Morphine-induced supraventricular tachycardia in near-term fetus

BACKGROUND: Fetal supraventricular tachycardia (SVT), characterized by fetal heart rate between 220 and 260 bpm, is a rare but most commonly encountered fetal cardiac arrhythmia in pregnancy that may be associated with adverse perinatal outcome. CASE PRESENTATION: We describe a 36/6 week near term f...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenzo, Zanardo, Alphonse, Simbi, Matteo, Parotto, Lorenzo, Severino, Riccardo, Carta, Pietro, Guerrini, Gianluca, Straface
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154430/
https://www.ncbi.nlm.nih.gov/pubmed/30249290
http://dx.doi.org/10.1186/s13052-018-0570-1
Descripción
Sumario:BACKGROUND: Fetal supraventricular tachycardia (SVT), characterized by fetal heart rate between 220 and 260 bpm, is a rare but most commonly encountered fetal cardiac arrhythmia in pregnancy that may be associated with adverse perinatal outcome. CASE PRESENTATION: We describe a 36/6 week near term fetus who presented morphine-induced SVT after maternal treatment of a renal colic. Following emergency cesarean section, the neonate had resolution of symptoms. CONCLUSIONS: The pathophysiology of morphine-related SVT, previously documented in experimental animal models, and for the first time reported in the human fetus, is presented.

Ejemplares similares